Articles Related to Pharmaceutical Development
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
Editorial Board Members Related to Pharmaceutical Development
Charles C. Muscoplat
Professor
Department of Food Science and Nutrition
University of Minnesota
United States
Department of Food Science and Nutrition
University of Minnesota
United States